Medcxy

Product dossierBuilt from registrations, label text and platform-curated data

润辉注射用透明质酸钠复合溶液

Ask about this product

润辉 is a Skin booster product (Class III device), registered by 润辉生物技术（威海）有限公司. Linked registrations: China 国械注准20263130779. First approved in China on 2026-04-21 (国械注准20263130779). Data as of 2026-10-24.

  • Regulatory classSkin booster · Class III device
  • Holder润辉生物技术（威海）有限公司
  • JurisdictionsCN
  • Updated2026-10-24 · v1

Registration and basics are public; findings and prices need an account

Registration and basics

润辉

Product
Regulatory class
Class III device
Category
Skin booster
China · NMPA device registration
国械注准20263130779
Name on registration
注射用透明质酸钠复合溶液
Registrant
润辉生物技术（威海）有限公司
First approval
2026-04-21
This certificate issued
2026-04-21
Valid until
2031-04-20
Models and sizes
型号：MESO-I，规格：1.0mL/瓶、2.0mL/瓶、2.5mL/瓶、3.0mL/瓶、3.5mL/瓶、4.0mL/瓶、5.0mL/瓶
Checked against official page
2026-10-23

Public: fields from the registration record.

Label facts by jurisdiction

What each jurisdiction's label says for the same attribute; gaps are marked Not reported, irrelevant ones N/A

No data yet

Registration timeline

  1. CN

    国械注准20263130779 first approved

  2. CN

    国械注准20263130779 change

    首次获批（受理号 CQZ2501101；2026年04月23日医疗器械批准证明文件送达信息）

  3. CN

    国械注准20263130779 change

    延续或变更注册获批（受理号 CQX2600932；2026年10月20日医疗器械批准证明文件送达信息）

  4. CN

    国械注准20263130779 change

    官网变更：一、结构及组成由“该产品由微生物发酵法制备的透明质酸钠、甘氨酸、丙氨酸、脯氨酸、磷酸氢二钠(十二水合物)、磷酸二氢钠（一水合物)、氯化钠、注射用水组成，经除菌过滤后封装于由西林瓶、胶塞、铝盖组成的容器密封系统中，透明质酸钠标示浓度为5mg/mL。以无菌状态提供，开封后一…

  5. CN

    国械注准20263130779 valid until

First approval, this certificate's issue date (updated after renewals or changes), changes and expiry are listed separately; a missing first approval means it was not obtained from an official source. Up to 6 recent changes per registration; click the number for the full record.

Cross findings · Price observations

Sign in to see findings and prices

Findings and prices stay out of indexable pages.

Sign in to view

Recent changes

3
  • 国械注准20263130779: 延续或变更注册获批（受理号 CQX2600932；2026年10月20日医疗器械批准证明文件送达信息）2026-10-16
  • 国械注准20263130779: 官网变更：一、结构及组成由“该产品由微生物发酵法制备的透明质酸钠、甘氨酸、丙氨酸、脯氨酸、磷酸氢二钠(十二水合物)、磷酸二氢钠（一水合物)、氯化钠、注射用水组成…2026-10-16
  • 国械注准20263130779: 首次获批（受理号 CQZ2501101；2026年04月23日医疗器械批准证明文件送达信息）2026-04-21

Sources

1